The Berlin-Canberra alliance addresses fundamental issues in malaria through an International Research Training Program (IRTG 2290). Molecular insights into Plasmodium infections can generate novel evidence-based strategies to develop curative and prophylactic drugs, and immunization strategies that elicit lasting protection against the disease.
The program covers four research areas:
All research projects will involve work carried out in both Berlin and Canberra and PhD students will graduate with a dual PhD from both the Humboldt University and the Australian National University. PhD students in the program will have the opportunity to participate in a customized training program that includes voluntary internships and that will support students in acquiring critical skills to prepare for increasingly globalized and competitive public and private job markets.
The IRTG 2290 is a member program of the Graduate School at the IRI Life Sciences and funded by the German Research Council.
The image on our website header depicts the sporozoite stage in the life-cycle of the malaria parasite. This image was kindly provided by Dr. Volker Brinkmann, Head of Microscopy at the Max Planck Institute for Infection Biology, in Berlin.
PhD Scholarships Available at HUB and ANU
- Join the Alliance! See applications
Check out the recent article in Scientific Reports "An in silico down-scaling approach uncovers novel constituents of the Plasmodium-containing vacuoles" coauthored by Joachim Matz and IRTG2290 Spokesperson Kai Matuschewski.
To learn about upcoming IRTG events please subscribe.
The Australian National University
Research School of Biology
134 Linnaeus Way
Canberra - Acton ACT 2601
Humboldt-Universität zu Berlin
Unter den Linden 6